[
  {
    "title": "科美诊断(688468.SH)：上海沛禧及其一致行动人已减持1.10%的股份",
    "href": "http://stock.jrj.com.cn/2023/01/04161737258484.shtml",
    "datetime": "2023-01-04 16:17:45",
    "code": "688468"
  },
  {
    "title": "A股异动 | 科美诊断(688468.SH)收跌4.17% 横琴君联致康以大宗交易减持1.05%股份",
    "href": "http://stock.jrj.com.cn/2022/12/19150237222377.shtml",
    "datetime": "2022-12-19 15:02:57",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)：横琴君联致康以大宗交易减持1.05%的股份",
    "href": "http://stock.jrj.com.cn/2022/12/16172437218564.shtml",
    "datetime": "2022-12-16 17:24:36",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)：减持数过半 上海沛禧及其一致行动人累计减持1.51%股份",
    "href": "http://stock.jrj.com.cn/2022/12/15182637215800.shtml",
    "datetime": "2022-12-15 18:26:10",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)：平安置业及其一致行动人近期累计减持1.04%股份",
    "href": "http://stock.jrj.com.cn/2022/12/02181337185192.shtml",
    "datetime": "2022-12-02 18:13:28",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)：上海沛禧及其一致行动人持股比例从13.13%减至11.93%",
    "href": "http://stock.jrj.com.cn/2022/11/22155737157470.shtml",
    "datetime": "2022-11-22 15:57:59",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)：平安置业及其一致行动人持股比例从8.50%减至7.45%",
    "href": "http://stock.jrj.com.cn/2022/11/18171437150380.shtml",
    "datetime": "2022-11-18 17:14:07",
    "code": "688468"
  },
  {
    "title": "科美诊断：股东拟合计减持不超过9%",
    "href": "http://stock.jrj.com.cn/2022/11/11155237131289.shtml",
    "datetime": "2022-11-11 15:52:59",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)：横琴君联致康及一致行动人、上海沛禧及一致行动人拟减持合计不超9%股份",
    "href": "http://stock.jrj.com.cn/2022/11/11155237131322.shtml",
    "datetime": "2022-11-11 15:52:15",
    "code": "688468"
  },
  {
    "title": "科美诊断4名股东合计减持1488.34万股 套现合计1.78亿 2022年前三季度公司净利1.18亿",
    "href": "http://stock.jrj.com.cn/2022/11/09191337125065.shtml",
    "datetime": "2022-11-09 19:13:20",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)：横琴君联致康及其一致行动人已减持1.05%的股份",
    "href": "http://stock.jrj.com.cn/2022/11/09165237124353.shtml",
    "datetime": "2022-11-09 16:52:50",
    "code": "688468"
  },
  {
    "title": "科美诊断：平安置业及其一致行动人拟减持不超过6%公司股份",
    "href": "http://stock.jrj.com.cn/2022/11/01155937103251.shtml",
    "datetime": "2022-11-01 15:59:05",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)：减持期届满 平安置业及平盛安康累计减持9.6万股",
    "href": "http://stock.jrj.com.cn/2022/10/31155937099797.shtml",
    "datetime": "2022-10-31 15:59:36",
    "code": "688468"
  },
  {
    "title": "科美诊断2022年前三季度净利1.18亿 同比增长9.69%",
    "href": "http://stock.jrj.com.cn/2022/10/29121237096610.shtml",
    "datetime": "2022-10-29 12:12:06",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)：第三季度净利增28.96%至4873.02万元",
    "href": "http://stock.jrj.com.cn/2022/10/28171437094272.shtml",
    "datetime": "2022-10-28 17:14:14",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)：减持期过半、平安置业及平盛安康尚未减持公司股份",
    "href": "http://stock.jrj.com.cn/2022/09/13161736991280.shtml",
    "datetime": "2022-09-13 16:17:14",
    "code": "688468"
  },
  {
    "title": "科美诊断披露2022年半年报 实现营收2.24亿元",
    "href": "http://stock.jrj.com.cn/2022/08/30093536951080.shtml",
    "datetime": "2022-08-30 09:35:59",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)：上半年实现净利润6952.06万元",
    "href": "http://stock.jrj.com.cn/2022/08/29160536947269.shtml",
    "datetime": "2022-08-29 16:05:08",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)：近日3项产品获得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/08/15162936900373.shtml",
    "datetime": "2022-08-15 16:29:16",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)：减持期过半 3名股东已合计减持2.61%股份",
    "href": "http://stock.jrj.com.cn/2022/08/09154836882812.shtml",
    "datetime": "2022-08-09 15:48:24",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)：上海沛禧已合计减持403.1403万股",
    "href": "http://stock.jrj.com.cn/2022/07/29173336854342.shtml",
    "datetime": "2022-07-29 17:33:52",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)：子公司获得1项发明专利证书",
    "href": "http://stock.jrj.com.cn/2022/07/21164736832257.shtml",
    "datetime": "2022-07-21 16:47:45",
    "code": "688468"
  },
  {
    "title": "科美诊断大股东拟减持1203万股 1.54亿商誉面临减值风险",
    "href": "http://stock.jrj.com.cn/2022/07/06084536786034.shtml",
    "datetime": "2022-07-06 08:45:00",
    "code": "688468"
  },
  {
    "title": "科美诊断：平安置业及一致人拟减持不超过3%股份",
    "href": "http://stock.jrj.com.cn/2022/07/05165136783816.shtml",
    "datetime": "2022-07-05 16:51:52",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)：平安置业及平盛安康拟合计减持不超3%的股份",
    "href": "http://stock.jrj.com.cn/2022/07/05164836783798.shtml",
    "datetime": "2022-07-05 16:48:30",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)2021年度权益分派10派1.7元 股权登记日为6月7日",
    "href": "http://stock.jrj.com.cn/2022/05/31180836693895.shtml",
    "datetime": "2022-05-31 18:08:31",
    "code": "688468"
  },
  {
    "title": "科美诊断（688468）：于上证路演中心举行投资者关系活动",
    "href": "http://stock.jrj.com.cn/2022/05/31083336691758.shtml",
    "datetime": "2022-05-31 08:33:47",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)获得2项发明专利",
    "href": "http://stock.jrj.com.cn/2022/05/19160736662280.shtml",
    "datetime": "2022-05-19 16:07:52",
    "code": "688468"
  },
  {
    "title": "科美诊断：获得两项医疗器械产品注册证 有助于提升公司市场综合竞争力",
    "href": "http://stock.jrj.com.cn/2022/05/16185836652553.shtml",
    "datetime": "2022-05-16 18:58:54",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)：2项产品获得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/05/16154836651279.shtml",
    "datetime": "2022-05-16 15:48:54",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)及子公司近日获得1项发明专利证书",
    "href": "http://stock.jrj.com.cn/2022/05/10170736621236.shtml",
    "datetime": "2022-05-10 17:07:58",
    "code": "688468"
  },
  {
    "title": "科美诊断2022年第一季度净利3910.73万同比增长2.54% 采购支出减少",
    "href": "http://stock.jrj.com.cn/2022/05/03205036547788.shtml",
    "datetime": "2022-05-03 20:50:55",
    "code": "688468"
  },
  {
    "title": "科美诊断2021年净利1.43亿同比增长21.99% 董事长李临薪酬176.22万",
    "href": "http://stock.jrj.com.cn/2022/05/02173236533031.shtml",
    "datetime": "2022-05-02 17:32:45",
    "code": "688468"
  },
  {
    "title": "科美诊断披露2022年一季报 实现营收1.21亿元",
    "href": "http://stock.jrj.com.cn/2022/04/28090736490328.shtml",
    "datetime": "2022-04-28 09:07:01",
    "code": "688468"
  },
  {
    "title": "科美诊断披露2021年年报 实现营收4.71亿元",
    "href": "http://stock.jrj.com.cn/2022/04/28090636490329.shtml",
    "datetime": "2022-04-28 09:06:40",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)：一季度实现净利润3910.73万元 同比增长2.54%",
    "href": "http://stock.jrj.com.cn/2022/04/27170336484735.shtml",
    "datetime": "2022-04-27 17:03:22",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)：2021年净利润增21.99%至1.43亿元 拟10派1.7元",
    "href": "http://stock.jrj.com.cn/2022/04/27170036484738.shtml",
    "datetime": "2022-04-27 17:00:44",
    "code": "688468"
  },
  {
    "title": "科美诊断：公司获得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/04/20114536408147.shtml",
    "datetime": "2022-04-20 11:45:22",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)：取得1项医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/04/19193836401458.shtml",
    "datetime": "2022-04-19 19:38:08",
    "code": "688468"
  },
  {
    "title": "科美诊断：多名股东拟合计减持不超11%股份",
    "href": "http://stock.jrj.com.cn/2022/04/15192036346274.shtml",
    "datetime": "2022-04-15 19:20:11",
    "code": "688468"
  },
  {
    "title": "科美诊断：获得三项发明专利证书 有利于进一步完善公司知识产权体系",
    "href": "http://stock.jrj.com.cn/2022/04/13172736325014.shtml",
    "datetime": "2022-04-13 17:27:12",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)：取得3项发明证书",
    "href": "http://stock.jrj.com.cn/2022/04/13155336323865.shtml",
    "datetime": "2022-04-13 15:53:03",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)：戊型肝炎病毒IgM抗体(HEV-IgM)检测试剂盒(光激化学发光法)获得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/04/08193236273727.shtml",
    "datetime": "2022-04-08 19:32:28",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)：荣获北京市2021年度第二批专精特新“小巨人”企业称号",
    "href": "http://stock.jrj.com.cn/2022/03/02154634511939.shtml",
    "datetime": "2022-03-02 15:46:37",
    "code": "688468"
  },
  {
    "title": "科美诊断2021年净利1.43亿 同比增长21.99%",
    "href": "http://stock.jrj.com.cn/2022/02/25223034468602.shtml",
    "datetime": "2022-02-25 22:30:30",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)：拟推2021年限制性股票激励计划",
    "href": "http://stock.jrj.com.cn/2021/12/27175234071556.shtml",
    "datetime": "2021-12-27 17:52:52",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)：5项产品获得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/12/14180934015169.shtml",
    "datetime": "2021-12-14 18:09:54",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)：人附睾蛋白4(HE4)检测试剂盒(化学发光法)获得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/11/29161233938098.shtml",
    "datetime": "2021-11-29 16:12:15",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)：丙型肝炎病毒抗原抗体(HCVAg/Ab)检测试剂盒(光激化学发光法)获得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/11/22155033903912.shtml",
    "datetime": "2021-11-22 15:50:07",
    "code": "688468"
  },
  {
    "title": "科美诊断披露前三季度实现营收3.55亿元，同比增长20.23%",
    "href": "http://stock.jrj.com.cn/2021/10/28181133770729.shtml",
    "datetime": "2021-10-28 18:11:44",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)：前三季度净利增40.74%至1.08亿元",
    "href": "http://stock.jrj.com.cn/2021/10/28161333769125.shtml",
    "datetime": "2021-10-28 16:13:27",
    "code": "688468"
  },
  {
    "title": "科美诊断：本次限售股上市日为10月11日 占总股本0.4267%",
    "href": "http://stock.jrj.com.cn/2021/09/26175733516586.shtml",
    "datetime": "2021-09-26 17:57:33",
    "code": "688468"
  },
  {
    "title": "科美诊断（688468.SH）：社会人口新格局，LiCA系列产品为生命保驾护航",
    "href": "http://stock.jrj.com.cn/2021/08/31184833362867.shtml",
    "datetime": "2021-08-31 18:48:59",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)上半年净利升124.65%至7001.55万元 LiCA试剂销量持续增长",
    "href": "http://stock.jrj.com.cn/2021/08/26190433325870.shtml",
    "datetime": "2021-08-26 19:04:34",
    "code": "688468"
  },
  {
    "title": "科美诊断2021年半年度净利7001.55万元 同比净利增加124.65%",
    "href": "http://stock.jrj.com.cn/2021/08/26183733325647.shtml",
    "datetime": "2021-08-26 18:37:55",
    "code": "688468"
  },
  {
    "title": "科美诊断：公司目前主要通过投放方式向客户提供检测仪器",
    "href": "http://stock.jrj.com.cn/2021/06/23195332984715.shtml",
    "datetime": "2021-06-23 19:53:57",
    "code": "688468"
  },
  {
    "title": "科美诊断：目前我国化学发光市场中 进口产品占据约80%的市场份额",
    "href": "http://stock.jrj.com.cn/2021/05/26112832822036.shtml",
    "datetime": "2021-05-26 11:28:27",
    "code": "688468"
  },
  {
    "title": "科美诊断：公司所采用的激发光为680nm的长波长激光 几乎不产生非特异性荧光",
    "href": "http://stock.jrj.com.cn/2021/05/26112832822037.shtml",
    "datetime": "2021-05-26 11:28:10",
    "code": "688468"
  },
  {
    "title": "资金需求较大 科美诊断2020年度拟不分配利润",
    "href": "http://stock.jrj.com.cn/2021/05/25101232815326.shtml",
    "datetime": "2021-05-25 10:12:38",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)拟以募集资金向博阳生物提供无息借款实施募投项目",
    "href": "http://stock.jrj.com.cn/2021/05/24191032811949.shtml",
    "datetime": "2021-05-24 19:10:41",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)一度大涨超16% 领涨板块",
    "href": "http://stock.jrj.com.cn/2021/05/17113232768401.shtml",
    "datetime": "2021-05-17 11:32:10",
    "code": "688468"
  },
  {
    "title": "科美诊断：公司LiCA系列拥有8个生殖内分泌激素类的产品注册证 可覆盖辅助生殖所需的检测领域",
    "href": "http://stock.jrj.com.cn/2021/04/30112332485799.shtml",
    "datetime": "2021-04-30 11:23:34",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)一季度扣非净利润升793.42%至3663.09万元",
    "href": "http://stock.jrj.com.cn/2021/04/28172532472532.shtml",
    "datetime": "2021-04-28 17:25:22",
    "code": "688468"
  },
  {
    "title": "研究 | 科美诊断四成发明专利受让自前创始人 千万元销售额真实性或遭拷问",
    "href": "http://stock.jrj.com.cn/2021/04/22205732425909.shtml",
    "datetime": "2021-04-22 20:57:56",
    "code": "688468"
  },
  {
    "title": "科美诊断：优先采取现金分红的分配方式",
    "href": "http://stock.jrj.com.cn/2021/04/21185332417730.shtml",
    "datetime": "2021-04-21 18:53:33",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)：上市后紧抓后疫情时代机遇 大力发展发展LiCA系列产品",
    "href": "http://stock.jrj.com.cn/2021/04/14125632370791.shtml",
    "datetime": "2021-04-14 12:56:38",
    "code": "688468"
  },
  {
    "title": "坐拥优质赛道，科美诊断（688468.SH）价值几何？",
    "href": "http://stock.jrj.com.cn/2021/04/13091532362715.shtml",
    "datetime": "2021-04-13 09:15:53",
    "code": "688468"
  },
  {
    "title": "科美诊断（688468.SH）：今日登录科创板，LiCA诊断有望引领国产替代",
    "href": "http://stock.jrj.com.cn/2021/04/09131132341177.shtml",
    "datetime": "2021-04-09 13:11:22",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)首日上市盘中最高涨超200%",
    "href": "http://stock.jrj.com.cn/2021/04/09101832339777.shtml",
    "datetime": "2021-04-09 10:18:12",
    "code": "688468"
  },
  {
    "title": "今日新股上市：中金辐照、中洲特材、共同药业、科美诊断",
    "href": "http://stock.jrj.com.cn/2021/04/09090932339053.shtml",
    "datetime": "2021-04-09 09:09:00",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)：公司股票4月9日起上市交易",
    "href": "http://stock.jrj.com.cn/2021/04/07191032326699.shtml",
    "datetime": "2021-04-07 19:10:11",
    "code": "688468"
  },
  {
    "title": "【兑奖啦】科创板科美诊断网上申购中签号出炉",
    "href": "http://stock.jrj.com.cn/ipo/2021/03/30193032249221.shtml",
    "datetime": "2021-03-30 19:30:37",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)：网上发行最终中签率为0.03256474%",
    "href": "http://stock.jrj.com.cn/2021/03/29191132242733.shtml",
    "datetime": "2021-03-29 19:11:48",
    "code": "688468"
  },
  {
    "title": "今日新股申购:科美诊断、华绿生物、恒帅股份、共同药业",
    "href": "http://stock.jrj.com.cn/2021/03/29084932238578.shtml",
    "datetime": "2021-03-29 08:49:00",
    "code": "688468"
  },
  {
    "title": "共同药业、恒帅股份、华绿生物、科美诊断3月29日申购",
    "href": "http://stock.jrj.com.cn/2021/03/26145832222573.shtml",
    "datetime": "2021-03-26 14:58:44",
    "code": "688468"
  },
  {
    "title": "科美诊断(688468.SH)：发行价定为7.15元/股 3月29日申购",
    "href": "http://stock.jrj.com.cn/2021/03/25191132217576.shtml",
    "datetime": "2021-03-25 19:11:31",
    "code": "688468"
  },
  {
    "title": "证监会同意科美诊断、和林科技、元琛科技、腾景科技、富信科技科创板IPO注册",
    "href": "http://stock.jrj.com.cn/2021/02/24202732020410.shtml",
    "datetime": "2021-02-24 20:27:00",
    "code": "688468"
  },
  {
    "title": "科美诊断聚焦优势赛道 国产替代可期",
    "href": "http://stock.jrj.com.cn/2021/02/09160931877590.shtml",
    "datetime": "2021-02-09 16:09:55",
    "code": "688468"
  },
  {
    "title": "科美诊断IPO过会：市场份额不足1% 去年商誉超净利",
    "href": "http://stock.jrj.com.cn/kcb/2020/11/27080531357273.shtml",
    "datetime": "2020-11-27 08:05:10",
    "code": "688468"
  },
  {
    "title": "科美诊断产品单一化仍“过会” 行业角逐激烈不容小觑",
    "href": "http://stock.jrj.com.cn/ipo/2020/11/04071431212718.shtml",
    "datetime": "2020-11-04 07:14:45",
    "code": "688468"
  },
  {
    "title": "科美诊断：今年科创板过会第153家 中信证券过22单",
    "href": "http://stock.jrj.com.cn/2020/10/27100831140449.shtml",
    "datetime": "2020-10-27 10:08:00",
    "code": "688468"
  },
  {
    "title": "科创板上市委：美迪凯、科美诊断首发10月26日上会",
    "href": "http://stock.jrj.com.cn/2020/10/16110931066413.shtml",
    "datetime": "2020-10-16 11:09:19",
    "code": "688468"
  },
  {
    "title": "美迪凯、科美诊断10月26日科创板首发上会",
    "href": "http://stock.jrj.com.cn/2020/10/16091031065614.shtml",
    "datetime": "2020-10-16 09:10:00",
    "code": "688468"
  },
  {
    "title": "科美诊断闯关科创板IPO：聚焦化学发光免疫检测 大额激励分配致两年连续亏损 | 产业新股",
    "href": "http://stock.jrj.com.cn/2020/09/22161230810043.shtml",
    "datetime": "2020-09-22 16:12:10",
    "code": "688468"
  },
  {
    "title": "10亿股权激励之后盯上科创板 科美诊断7000万侵权纠纷未结有何影响",
    "href": "http://stock.jrj.com.cn/kcb/2020/07/23072930319857.shtml",
    "datetime": "2020-07-23 07:29:31",
    "code": "688468"
  },
  {
    "title": "科美诊断科创板IPO获受理 先后获多家知名投资机构投资",
    "href": "http://stock.jrj.com.cn/2020/06/24144730009503.shtml",
    "datetime": "2020-06-24 14:47:00",
    "code": "688468"
  },
  {
    "title": "免疫诊断产品提供商科美诊断冲刺科创板 曾获君联资本、经纬中国等投资",
    "href": "http://stock.jrj.com.cn/kcb/2019/12/27085128594487.shtml",
    "datetime": "2019-12-27 08:51:50",
    "code": "688468"
  }
]